Home / Top News / U.S. panel rejects Philip Morris claim iQOS device cuts disease risk

U.S. panel rejects Philip Morris claim iQOS device cuts disease risk

WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.

Read Full Story